Belgian Retail REITs Stock News

It's been a good week for Lotus Bakeries NV ( EBR:LOTB ) shareholders, because the company has just released its latest...

If you have been wondering whether Anheuser-Busch InBev shares are offering good value at current levels, this article walks through what the numbers are actually saying about the stock. The share price recently closed at US$63.66, with reported returns of 4.2% over 7 days, 12.6% over 30 days, 17.0% year to date, 32.3% over 1 year, 20.1% over 3 years, and 23.4% over 5 years. These figures provide useful context before assessing what the business might be worth. Recent coverage around...

Lotus Bakeries (ENXTBR:LOTB) has wrapped up FY 2025 with second half revenue of €697.7 million, basic EPS of €114.31 and net income of €92.9 million, while trailing twelve month revenue sits at about €1.4 billion with EPS of €212.06. The company has seen revenue move from €632.7 million in the second half of 2024 to €657.3 million in the first half of 2025 and €697.7 million in the second half of 2025. EPS over the same periods stepped from €99.12 to €97.74 and then €114.31, setting up a...

Key Insights Significant control over Groupe Bruxelles Lambert by private companies implies that the general public has...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Umicore fair value estimate is €29.83 Umicore's €19.68 share...

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...

Orange Belgium (ENXTBR:OBEL) FY 2025 Earnings Snapshot Orange Belgium (ENXTBR:OBEL) has just reported its FY 2025 numbers with first half revenue of €962.7 million and basic EPS of €0.04, alongside trailing 12 month revenue of €1.96 billion and EPS of €0.61 that frame the latest run rate. The company recorded revenue of €977.5 million in the first half of 2024 and €1,016.2 million in the second half of 2024, while EPS moved from a loss of €0.20 to a profit of €0.56, before landing at €0.04 in...

Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €1.68 per share on the 21st of May. This makes the...

Argenx's Vyvgart is significantly outperforming expectations, with recent sales figures pointing to stronger than anticipated demand. The company is preparing for major Phase 3 trial readouts that are expected to clarify the potential of its broader pipeline. These developments are drawing attention from healthcare investors who view Vyvgart as an important contributor to fund performance. argenx (ENXTBR:ARGX) is drawing fresh interest as Vyvgart's performance adds weight to its current...

Key Insights Banqup Group's significant individual investors ownership suggests that the key decisions are influenced...

Despite an already strong run, DEME Group NV ( EBR:DEME ) shares have been powering on, with a gain of 26% in the last...

UCB has received European Union approval for Kygevi to treat thymidine kinase 2 deficiency (TK2d) in patients whose disease began before age 12, marking the first EU-authorized therapy for this rare genetic condition. The decision builds on prior FDA approval and retrospective data showing a very large reduction in risk of death versus untreated TK2d patients, underscoring Kygevi’s medical significance for a small but highly underserved population. We’ll now examine how Kygevi’s first-in-EU...

With a price-to-earnings (or "P/E") ratio of 13x Colruyt Group N.V. ( EBR:COLR ) may be sending bullish signals at the...

In January, argenx reported continued momentum for its autoimmune drug VYVGART, as the US FDA accepted a priority review of a supplemental biologics license application to extend its use to adults with acetylcholine receptor antibody‑seronegative generalized myasthenia gravis, while the franchise continued to post strong global sales growth in 2025. This combination of regulatory progress and broader clinical ambitions, spanning indications like immune thrombocytopenia, myositis and...

Warehouses De Pauw (ENXTBR:WDP) has wrapped up FY 2025 with fourth quarter revenue of €135.6 million and basic EPS of €0.46. This sits against a trailing 12 month picture that includes €545.8 million of revenue and EPS of €1.54. Over recent periods, revenue has moved from €116.1 million and EPS of €0.57 in Q4 2024 to €135.6 million and EPS of €0.46 in Q4 2025. The trailing 12 month net profit margin is reported at 71.4% for the latest year compared with 61.5% a year earlier, and that margin...

UBS Group AG has fallen below the 3% voting rights threshold in Solvay (ENXTBR:SOLB), according to recent Belgian transparency notifications. The change reflects an adjustment in UBS Group AG's shareholding that may matter for investors tracking Solvay's ownership profile. Solvay, a Belgium based chemicals group, operates in specialty materials, energy transition themes and a wide range of industrial end markets. For you as an investor, shifts in the register involving large institutions...

The Lotus Bakeries NV ( EBR:LOTB ) share price has done very well over the last month, posting an excellent gain of...

The Cmb.Tech NV ( EBR:CMBT ) share price has done very well over the last month, posting an excellent gain of 26...

Barco recently launched weConnect, a cloud-based collaborative learning platform for higher education that supports device connectivity, remote participation, and teacher moderation through a simple web app. The move highlights how Barco is targeting digitally enabled, student-centric learning environments, positioning its technology more directly within the evolving education-technology ecosystem. We will now explore how the higher-education focus of weConnect could shape Barco’s broader...

VGP NV recently reported the past completion of its capped tender offer for its outstanding €500,000,000 1.625% green bonds due January 2027, accepting €100,000,000 of the €320,100,000 then outstanding and confirming that the New Issue Condition was met. This move highlights VGP’s active approach to managing its green bond liabilities and refining its capital structure through selective early repayment. Next, we will explore how this targeted €100,000,000 green bond buyback shapes VGP’s...

Key Insights The considerable ownership by retail investors in Syensqo indicates that they collectively have a greater...

Cenergy Holdings SA ( EBR:CENER ) shareholders have had their patience rewarded with a 28% share price jump in the last...

AB InBev has secured an exclusive beer and cider partnership with Live Nation in the UK. The agreement connects AB InBev brands to major music festivals and venues, targeting millions of attendees. The partnership focuses on immersive on site experiences and expanded visibility for the brewer's portfolio. For investors watching Anheuser-Busch InBev, ticker ENXTBR:ABI, this Live Nation deal links a global brewer with one of the UK's largest live entertainment platforms. With the current...

DEME has taken delivery of its second new wind turbine installation vessel, Norse Energi, from CIMC Raffles Shipyard, a purpose-built ship designed to handle the next generation of large-scale offshore wind turbines with advanced lifting, loading, and sustainability features. By pairing Norse Energi with its sister vessel Norse Wind, DEME is expanding a specialized fleet that could enhance its role in complex offshore wind installation projects worldwide. We will now examine how this...